DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

131.09 2.59 (2.02%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALNY $131.09 2.02%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $128.98
Previous Close $128.50
Daily Range $128.40 - $133.96
52-Week Range $51.93 - $133.96
Market Cap $11.0B
P/E Ratio -72.60
Dividend (Yield) $0.00 (0.0%)
Volume 3,431,344
Average Daily Volume 777,671
Current FY EPS -$2.96

Sector

Healthcare

Industry

Drug Makers

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary

Alnylam Pharmaceuticals, Inc.'s Five-Year Plan

The biotech updated investors on its Alnylam 2020 plan during its first-quarter earnings announcement.

Alnylam (ALNY) Begins Phase I Study on Liver Disease Drug - Analyst Blog

4 Big Biotech Companies to Sell Now

Alnylam Begins Phase 1 Clincial Trial For ALN-AS!

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

Alnylam Files Clinical Trial Application for ALN-AAT - Analyst Blog

After-Hours Movers Friday: Seventy Seven Energy, Kite Pharma

3 Health Care Stocks Nudging The Sector Higher

Alnylam's Q1 Loss Narrower than Expected, Confirms Guidance - Analyst Blog

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Alibaba, CyberArk, Yelp, Rocket Fuel, Choice Ho

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Alibaba, CyberArk, Yelp, Rocket Fuel, Choice Hotels and More

See More ALNY News...

ALNY's Top Competitors

ALNY $131.09 (2.02%)
Current stock: ALNY
AMGN $156.26 (-0.69%)
Current stock: AMGN
GILD $112.27 (-0.51%)
Current stock: GILD
BIIB $396.99 (-0.78%)
Current stock: BIIB